{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-080011","form_type":"8-K","ticker":"RBOT","cik":"0001812173","company_name":"Vicarious Surgical Inc.","filed_at":"2026-07-21T20:10:43+00:00","discovered_at":"2026-07-21T20:12:01.300844+00:00","generated_at":"2026-07-21T20:12:27.529314+00:00","sec_items":["1.01","2.01","5.02","5.07","8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"Vicarious Surgical to liquidate via assignment for benefit of creditors; stockholders likely receive nothing","bullets":["Stockholders approved assignment for benefit of creditors and voluntary dissolution at July 21 special meeting; 13.3M votes for, 100.9K against.","All directors resigned effective upon filing Form 15 to deregister common stock; CEO, President, CTO, CMO terminated with severance (CEO $672,699, President $779,190, CTO $611,261).","Company will file Form 15 to deregister common stock due to fewer than 300 holders of record; expects deregistration effective 90 days after filing.","Creditors have priority over stockholders; stockholders are not expected to receive any distribution from assigned assets.","Assignment Agreement transfers all assignable assets to Vicarious Liquidation, LLC for benefit of creditors; contracts and employee benefit plans excluded."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-080011","json":"https://secwatch.observer/filing/0001213900-26-080011.json","markdown":"https://secwatch.observer/filing/0001213900-26-080011.md","text":"https://secwatch.observer/filing/0001213900-26-080011.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1812173/000121390026080011/0001213900-26-080011-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1812173/000121390026080011/ea0298707-8k_vicarious.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-21T20:12:27.529314+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"048865220e","claim":"Victoria Carr-Brendel resigned as Director at Vicarious Surgical Inc..","evidence_excerpt":"each of the members of the Board (Joseph Doherty, Stephen From, Adam Sachs, Sammy Khalifa, David Ho, Victoria Carr-Brendel, and Fuad Ahmad), each provided notice of his or her decision to resign from the Board and all committees thereof, effective upon the filing of the Form 15 with the Securities and Exchange Commission (the “SEC”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1812173/000121390026080011/0001213900-26-080011-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"05918aa2df","claim":"Sammy Khalifa resigned as Director at Vicarious Surgical Inc..","evidence_excerpt":"each of the members of the Board (Joseph Doherty, Stephen From, Adam Sachs, Sammy Khalifa, David Ho, Victoria Carr-Brendel, and Fuad Ahmad), each provided notice of his or her decision to resign from the Board and all committees thereof, effective upon the filing of the Form 15 with the Securities and Exchange Commission (the “SEC”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1812173/000121390026080011/0001213900-26-080011-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"2094ca2dff","claim":"Stephen From was terminated as Chief Executive Officer at Vicarious Surgical Inc..","evidence_excerpt":"the Company terminated the employment of each of Stephen From, the Company’s Chief Executive Officer, Adam Sachs, the Company’s President, Sammy Khalifa, the Company’s Chief Technology Officer, and Dr. Barry Greene, the Company’s Chief Medical Officer, effective as of the close of business on July 21, 2026.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1812173/000121390026080011/0001213900-26-080011-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"2ff7d82534","claim":"Sammy Khalifa was terminated as Chief Technology Officer at Vicarious Surgical Inc..","evidence_excerpt":"the Company terminated the employment of each of Stephen From, the Company’s Chief Executive Officer, Adam Sachs, the Company’s President, Sammy Khalifa, the Company’s Chief Technology Officer, and Dr. Barry Greene, the Company’s Chief Medical Officer, effective as of the close of business on July 21, 2026.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1812173/000121390026080011/0001213900-26-080011-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"Chief Technology Officer"}],"fact_type":"executive_change"},{"claim_id":"7668fcb701","claim":"Adam Sachs resigned as Director at Vicarious Surgical Inc..","evidence_excerpt":"each of the members of the Board (Joseph Doherty, Stephen From, Adam Sachs, Sammy Khalifa, David Ho, Victoria Carr-Brendel, and Fuad Ahmad), each provided notice of his or her decision to resign from the Board and all committees thereof, effective upon the filing of the Form 15 with the Securities and Exchange Commission (the “SEC”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1812173/000121390026080011/0001213900-26-080011-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"76cc842d91","claim":"David Ho resigned as Director at Vicarious Surgical Inc..","evidence_excerpt":"each of the members of the Board (Joseph Doherty, Stephen From, Adam Sachs, Sammy Khalifa, David Ho, Victoria Carr-Brendel, and Fuad Ahmad), each provided notice of his or her decision to resign from the Board and all committees thereof, effective upon the filing of the Form 15 with the Securities and Exchange Commission (the “SEC”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1812173/000121390026080011/0001213900-26-080011-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"be092cb179","claim":"Stephen From resigned as Director at Vicarious Surgical Inc..","evidence_excerpt":"each of the members of the Board (Joseph Doherty, Stephen From, Adam Sachs, Sammy Khalifa, David Ho, Victoria Carr-Brendel, and Fuad Ahmad), each provided notice of his or her decision to resign from the Board and all committees thereof, effective upon the filing of the Form 15 with the Securities and Exchange Commission (the “SEC”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1812173/000121390026080011/0001213900-26-080011-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"beb22e5098","claim":"Fuad Ahmad resigned as Director at Vicarious Surgical Inc..","evidence_excerpt":"each of the members of the Board (Joseph Doherty, Stephen From, Adam Sachs, Sammy Khalifa, David Ho, Victoria Carr-Brendel, and Fuad Ahmad), each provided notice of his or her decision to resign from the Board and all committees thereof, effective upon the filing of the Form 15 with the Securities and Exchange Commission (the “SEC”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1812173/000121390026080011/0001213900-26-080011-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"c3ffaa34c5","claim":"Dr. Barry Greene was terminated as Chief Medical Officer at Vicarious Surgical Inc..","evidence_excerpt":"the Company terminated the employment of each of Stephen From, the Company’s Chief Executive Officer, Adam Sachs, the Company’s President, Sammy Khalifa, the Company’s Chief Technology Officer, and Dr. Barry Greene, the Company’s Chief Medical Officer, effective as of the close of business on July 21, 2026.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1812173/000121390026080011/0001213900-26-080011-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"Chief Medical Officer"}],"fact_type":"executive_change"},{"claim_id":"efb756dd2e","claim":"Adam Sachs was terminated as President at Vicarious Surgical Inc..","evidence_excerpt":"the Company terminated the employment of each of Stephen From, the Company’s Chief Executive Officer, Adam Sachs, the Company’s President, Sammy Khalifa, the Company’s Chief Technology Officer, and Dr. Barry Greene, the Company’s Chief Medical Officer, effective as of the close of business on July 21, 2026.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1812173/000121390026080011/0001213900-26-080011-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"President"}],"fact_type":"executive_change"},{"claim_id":"ff921272e7","claim":"Joseph Doherty resigned as Director at Vicarious Surgical Inc..","evidence_excerpt":"each of the members of the Board (Joseph Doherty, Stephen From, Adam Sachs, Sammy Khalifa, David Ho, Victoria Carr-Brendel, and Fuad Ahmad), each provided notice of his or her decision to resign from the Board and all committees thereof, effective upon the filing of the Form 15 with the Securities and Exchange Commission (the “SEC”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1812173/000121390026080011/0001213900-26-080011-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}